E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/26/2006 in the Prospect News Biotech Daily.

PRA on hold by Jefferies

Jefferies & Co., Inc. analyst David Windley maintained PRA International, Inc. at hold and a $25 price target. The analyst is looking for evidence of progress in diversifying therapeutic areas and expansion of the platform/presence in phase 1 and into phase 4. Shares of the Reston, Va., contract research organization were up 35 cents, or 1.45%, at $24.55 on volume of 135,492 shares versus the three-month running average of 248,098 shares. (Nasdaq: PRAI)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.